Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes

NCT07282054 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

550

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: THDB0206
DRUG: Insulin Lispro
DRUG: Insulin Glargine

Sponsor

Tonghua Dongbao Pharmaceutical Co.,Ltd